Cleared Traditional

K872704 - AMASTIM 2000

K872704 is an FDA 510(k) clearance for AMASTIM 2000, manufactured by Amatech International, Inc.. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 199-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1988
Decision
199d
Days
Class 2
Risk

K872704 is an FDA 510(k) clearance for the AMASTIM 2000. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Amatech International, Inc. (Houston, US). The FDA issued a Cleared decision on January 22, 1988 after a review of 199 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K872704

510(k) Number K872704 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 07, 1987
Decision Date January 22, 1988
Days to Decision 199 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
50d slower than avg
Panel avg: 149d · This submission: 199d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 605
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K872704.
PREMIER 10S (TENS)
K881424 · American Imex · Apr 1988
ULTIMA XS (TENS)
K880751 · American Imex · Apr 1988
LUMISCOPE TENS MODEL 2000T OR APCC 3001 OR PAIN RE
K880452 · Lumiscope Co., Inc. · Mar 1988
MEC-I-TRON, MODEL P-1
K873190 · Meyer Equipment Company, Inc. · Dec 1987
REBUILDER(TM)
K874085 · Micromed, Inc. · Dec 1987
TX-2(TENS)
K874333 · Oms Medico, Inc. · Nov 1987